Research location
Aberdeen
United Kingdom
Advertisement
Research activity in Aberdeen
United KingdomCureCurrent currently publishes aggregate city-level research activity for this location: 187 trials and 188 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Aberdeen
187 linked trials · page 2 of 4Plasma Analysis for Response Assessment and to DIrect the manaGement of Metastatic Prostate CancerNCT04067713 · 2019-09-20 · 1 site observation
ACTIVE_NOT_RECRUITING
Is Dietary Nitrate Effective in Reducing Aerobic Glycolysis in Breast Cancer?NCT03944226 · 2019-08-01 · 1 site observation
COMPLETED
A Heart Disease Study of Semaglutide in Patients With Type 2 DiabetesNCT03914326 · 2019-06-17 · 1 site observation
COMPLETED
A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney DiseaseNCT03819153 · 2019-06-17 · 1 site observation
COMPLETED
Assessing the Effects of a Buckwheat Beverage on Postprandial Glucose Metabolism on Healthy and T2D IndividualsNCT03923205 · 2019-03-07 · 1 site observation
COMPLETED
Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)NCT03443973 · 2018-08-22 · 1 site observation
TERMINATED
Lowering Events in Non-proliferative Retinopathy in ScotlandNCT03439345 · 2018-07-23 · 1 site observation
COMPLETED
A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its SafetyNCT03541174 · 2018-06-18 · 1 site observation
COMPLETED
To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.NCT03330847 · 2018-03-07 · 1 site observation
ACTIVE_NOT_RECRUITING
HR+/HER2- Advanced Breast Cancer and Endocrine ResistanceNCT03322215 · 2017-10-24 · 1 site observation
TERMINATED
The Meal Time StudyNCT03305237 · 2017-10-24 · 1 site observation
COMPLETED
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up StudiesNCT03269175 · 2017-09-29 · 1 site observation
COMPLETED
Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular HypertensionNCT03284853 · 2017-09-05 · 1 site observation
COMPLETED
Lessening the Impact of Fatigue in Inflammatory Rheumatic DiseasesNCT03248518 · 2017-09-05 · 1 site observation
COMPLETED
Commercial Prebiotic Supplement StudyNCT03141710 · 2017-05-10 · 1 site observation
COMPLETED
A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer SpecimensNCT03092739 · 2017-05-03 · 1 site observation
COMPLETED
The Big Breakfast StudyNCT03077295 · 2017-04-05 · 1 site observation
COMPLETED
A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 DiabetesNCT02692716 · 2017-01-17 · 1 site observation
COMPLETED
Deciphering Afatinib Response and Resistance With INtratumour HeterogeneityNCT02183883 · 2016-12-16 · 1 site observation
COMPLETED
Effect of FISH Intake on MEtabolic Health in a Diabetic South Asian popuLation (FISH MEAL)NCT02840630 · 2016-10-01 · 1 site observation
COMPLETED
Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular PrognosisNCT02831608 · 2016-10-01 · 1 site observation
COMPLETED
BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.NCT02788513 · 2016-08-11 · 1 site observation
COMPLETED
Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMANNCT02642562 · 2016-08-01 · 1 site observation
COMPLETED
Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2NCT02660359 · 2016-07-08 · 1 site observation
TERMINATED
European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study (LCS)NCT02804789 · 2016-05-01 · 1 site observation
TERMINATED
Thermic Effects of Some Scottish Plant FoodsNCT02937298 · 2016-05-01 · 1 site observation
COMPLETED
Estimating Quality of Life in People With AsthmaNCT02771678 · 2016-05-01 · 1 site observation
COMPLETED
LUME BioNIS: a Biomarker Study in Patients With NSCLCNCT02671422 · 2016-03-09 · 1 site observation
COMPLETED
Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid TumorsNCT02715284 · 2016-03-07 · 1 site observation
ACTIVE_NOT_RECRUITING
Prescribing Asthma Controller Medication According to Gene Status to Improve Quality of Life in Young People With AsthmaNCT02758873 · 2016-02-01 · 1 site observation
COMPLETED
An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLASNCT02531516 · 2015-11-19 · 1 site observation
ACTIVE_NOT_RECRUITING
Mindfulness-based Cognitive Therapy to Improve Emotional Wellbeing and Glycaemic Control in DiabetesNCT02600091 · 2015-10-30 · 1 site observation
COMPLETED
Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes MellitusNCT02465515 · 2015-07-01 · 1 site observation
COMPLETED
National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung CancerNCT02664935 · 2015-05-13 · 1 site observation
COMPLETED
Safety & Efficacy Study of EGF Cancer Vaccine to Treat Stage IV Biomarker Positive, Wild Type EGF-R NSCLC PatientsNCT02187367 · 2015-05-01 · 1 site observation
TERMINATED
Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapyNCT02129699 · 2015-01-06 · 1 site observation
TERMINATED
LUMINIST: LUng Cancer Molecular Insights Non Interventional StudyNCT02300831 · 2014-12-01 · 1 site observation
COMPLETED
A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide AloneNCT02288247 · 2014-12-01 · 1 site observation
COMPLETED
Effect of Soft Fruit on Postprandial Blood GlucoseNCT02291250 · 2014-11-01 · 1 site observation
UNKNOWN
AZD9291 (Osimertinib) Versus Platinum-Based Doublet-Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung CancerNCT02151981 · 2014-08-04 · 1 site observation
COMPLETED
Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)NCT02245568 · 2014-08-01 · 1 site observation
TERMINATED
Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryNCT02138916 · 2014-06-13 · 1 site observation
COMPLETED
TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)NCT01888601 · 2014-04-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.NCT02000622 · 2014-03-27 · 1 site observation
COMPLETED
A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic AgentNCT02046603 · 2014-03-04 · 1 site observation
COMPLETED
Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic NephropathyNCT02065791 · 2014-02-17 · 1 site observation
COMPLETED
SATIN: Satiety Innovation. Study 2- University of AberdeenNCT02604316 · 2014-01-01 · 1 site observation
COMPLETED
Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLCNCT01933932 · 2013-09-25 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart FailureNCT01877915 · 2013-09-10 · 1 site observation
COMPLETED
Follow-up Study After 11 Years of Patients Who Were Included in the BENEFIT Trial (304747) With a First Demyelinating Event Suggestive of Multiple SclerosisNCT01795872 · 2013-09-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.